Osteoclasts are essential for TNF-α-mediated joint destruction.
The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
The detailed cellular and molecular mechanisms leading to joint destruction in rheumatoid arthritis, a disease driven by proinflammatory cytokines, are still unknown. To address the question of whether osteoclasts play a pivotal role in this process, transgenic mice that express human TNF (hTNFtg) and that develop a severe and destructive arthritis were crossed with osteopetrotic, c-fos–deficient mice (c-fos–/–) completely lacking osteoclasts. The resulting mutant mice (c-fos–/–hTNFtg) developed a TNF-dependent arthritis in the absence of osteoclasts. All clinical features of arthritis, such as paw swelling and reduction of grip strength, progressed equally in both groups. Histological evaluation of joint sections revealed no difference in the extent of synovial inflammation, its cellular composition (except for the lack of osteoclasts), and the expression of matrix metalloprotein-ase-3 (MMP-3) and MMP-13. In addition, cartilage damage, proteoglycan loss, and MMP-3, -9, and -13 expression in chondrocytes were similar in hTNFtg and c-fos–/–hTNFtg mice. However, despite the presence of severe inflammatory changes, c-fos–/–hTNFtg mice were fully protected against bone destruction. These data reveal that TNF-dependent bone erosion is mediated by osteoclasts and that the absence of osteoclasts alters TNF-mediated arthritis from a destructive to a nondestructive arthritis. Therefore, in addition to the use of anti-inflammatory therapies, osteoclast inhibition could be beneficial for the treatment of rheumatoid arthritis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Certainly the high circulating levels of TNF-␣ and IL-1 that are common in RA have the potential to promote osteoclastogenesis throughout the skeleton (223,237,(423)(424)(425).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [425]
Citations
Cites
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,228
Bone Resorption by Osteoclasts
Teitelbaum, S. L. (2000) · Science · doi:10.1126/science.289.5484.1504 · Cited by 3,962
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
Lipsky, P. E., van der Heijde, D. M. F. M., St. Clair, E. W., Furst, D. E., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Weisman, M., Emery, P., Feldmann, M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432202 · Cited by 2,996
Self-citationROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.397 · Cited by 2,514
Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., & Martin, T. J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0367 · Cited by 2,336
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290
Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.
Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D., & Kollias, G. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04978.x · Cited by 1,660
Self-citation
Research works printed but not linked: 4
- Okada, 1995, Lab Invest, 72, 311
- Pap, 1999, J Rheumatol, 26, 166
- Gravallese, 1998, Am J Pathol, 152, 943
- Douni, 1995, J Inflamm, 47, 27
Cited by
Smolen, J. S., Aletaha, D., & McInnes, I. B. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30173-8 · Cited by 4,870
Self-citationEvolving concepts of rheumatoid arthritis
Firestein, G. S. (2003) · Nature · doi:10.1038/nature01661 · Cited by 3,605
Cytokines in the pathogenesis of rheumatoid arthritis
McInnes, I. B., & Schett, G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2094 · Cited by 2,529
Self-citationOsteoimmunology: shared mechanisms and crosstalk between the immune and bone systems
Takayanagi, H. (2007) · Nature Reviews Immunology · doi:10.1038/nri2062 · Cited by 1,878
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Tracey, D., Klareskog, L., Sasso, E. H., Salfeld, J. G., & Tak, P. P. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.10.001 · Cited by 1,628
Sato, K., Suematsu, A., Okamoto, K., Yamaguchi, A., Morishita, Y., Kadono, Y., Tanaka, S., Kodama, T., Akira, S., Iwakura, Y., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061775 · Cited by 1,554
Dickkopf-1 is a master regulator of joint remodeling
Diarra, D., Stolina, M., Polzer, K., Zwerina, J., Ominsky, M. S., Dwyer, D., Korb, A., Smolen, J., Hoffmann, M., Scheinecker, C., et al. (2007) · Nature Medicine · doi:10.1038/nm1538 · Cited by 1,298
Self-citationNew therapies for treatment of rheumatoid arthritis
Smolen, J. S., Aletaha, D., Koeller, M., Weisman, M. H., & Emery, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60784-3 · Cited by 995
Self-citationBone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment
Schett, G., & Gravallese, E. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.153 · Cited by 947
Self-citationTherapeutic strategies for rheumatoid arthritis
Smolen, J. S., & Steiner, G. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1109 · Cited by 911
Self-citationInflammatory bone loss: pathogenesis and therapeutic intervention
Redlich, K., & Smolen, J. S. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3669 · Cited by 830
Self-citationKearns, A. E., Khosla, S., & Kostenuik, P. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0014 · Cited by 824
Klareskog, L., Catrina, A. I., & Paget, S. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60008-8 · Cited by 787
IL-1 mediates TNF-induced osteoclastogenesis
Wei, S., Kitaura, H., Zhou, P., Ross, F. P., & Teitelbaum, S. L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523394 · Cited by 795
Mechanisms of joint destruction in rheumatoid arthritis — immune cell–fibroblast–bone interactions
Komatsu, N., & Takayanagi, H. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00793-5 · Cited by 527
Signaling pathways in rheumatoid arthritis: implications for targeted therapy
Ding, Q., Hu, W., Wang, R., Yang, Q., Zhu, M., Li, M., Cai, J., Rose, P., Mao, J., & Zhu, Y. Z. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01331-9 · Cited by 478
Fos/AP‐1 proteins in bone and the immune system
Wagner, E. F., & Eferl, R. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00332.x · Cited by 537
Self-citationJimi, E., Aoki, K., Saito, H., D'Acquisto, F., May, M. J., Nakamura, I., Sudo, T., Kojima, T., Okamoto, F., Fukushima, H., et al. (2004) · Nature Medicine · doi:10.1038/nm1054 · Cited by 501
Osteoimmunology and the effects of the immune system on bone
Takayanagi, H. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.217 · Cited by 487
Smolen, J. S., Han, C., Bala, M., Maini, R. N., Kalden, J. R., van der Heijde, D., Breedveld, F. C., Furst, D. E., Lipsky, P. E., & ATTRACT Study Group (2005) · Arthritis & Rheumatism · doi:10.1002/art.20982 · Cited by 462
Self-citationCadherin-11 in Synovial Lining Formation and Pathology in Arthritis
Lee, D. M., Kiener, H. P., Agarwal, S. K., Noss, E. H., Watts, G. F. M., Chisaka, O., Takeichi, M., & Brenner, M. B. (2007) · Science · doi:10.1126/science.1137306 · Cited by 420
van der Heijde, D., Salonen, D., Weissman, B. N., Landewé, R., Maksymowych, W. P., Kupper, H., Ballal, S., Gibson, E., Wong, R., & the Canadian (M03-606) study group and the ATLAS study group (2009) · Arthritis Research & Therapy · doi:10.1186/ar2794 · Cited by 413
Rheumatic diseases: the effects of inflammation on bone
Walsh, N. C., Crotti, T. N., Goldring, S. R., & Gravallese, E. M. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00338.x · Cited by 380
Aliprantis, A. O., Ueki, Y., Sulyanto, R., Park, A., Sigrist, K. S., Sharma, S. M., Ostrowski, M. C., Olsen, B. R., & Glimcher, L. H. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35711 · Cited by 350
Durán, A., Serrano, M., Leitges, M., Flores, J. M., Picard, S., Brown, J. P., Moscat, J., & Diaz-Meco, M. T. (2004) · Developmental Cell · doi:10.1016/s1534-5807(03)00403-9 · Cited by 316
Zwerina, J., Hayer, S., Tohidast‐Akrad, M., Bergmeister, H., Redlich, K., Feige, U., Dunstan, C., Kollias, G., Steiner, G., Smolen, J., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.11487 · Cited by 307
Self-citationSubchondral bone as a key target for osteoarthritis treatment
Castañeda, S., Roman-Blas, J. A., Largo, R., & Herrero-Beaumont, G. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.09.018 · Cited by 287
Regulation of TNF-Induced Osteoclast Differentiation
Yao, Z., Getting, S. J., & Locke, I. C. (2021) · Cells · doi:10.3390/cells11010132 · Cited by 280
Osteoporosis in Inflammatory Bowel Disease
Ali, T., Lam, D., Bronze, M. S., & Humphrey, M. B. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.01.022 · Cited by 266
The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis
Schett, G., Zwerina, J., & Firestein, G. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.074278 · Cited by 271
Self-citationInflammatory bone destruction and osteoimmunology
Takayanagi, H. (2005) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2005.00814.x · Cited by 270
Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo
Axmann, R., Böhm, C., Krönke, G., Zwerina, J., Smolen, J., & Schett, G. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24781 · Cited by 263
Self-citationDankbar, B., Fennen, M., Brunert, D., Hayer, S., Frank, S., Wehmeyer, C., Beckmann, D., Paruzel, P., Bertrand, J., Redlich, K., et al. (2015) · Nature Medicine · doi:10.1038/nm.3917 · Cited by 262
Self-citationEssential role of microRNA‐155 in the pathogenesis of autoimmune arthritis in mice
Blüml, S., Bonelli, M., Niederreiter, B., Puchner, A., Mayr, G., Hayer, S., Koenders, M. I., van den Berg, W. B., Smolen, J., & Redlich, K. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30281 · Cited by 253
Self-citationMechanisms and control of pathologic bone loss in periodontitis
Bartold, P. M., Cantley, M. D., & Haynes, D. R. (2010) · Periodontology 2000 · doi:10.1111/j.1600-0757.2010.00347.x · Cited by 254
Osteoclast precursors, RANKL/RANK, and immunology
Xing, L., Schwarz, E. M., & Boyce, B. F. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00336.x · Cited by 231
Henriksen, K., Bollerslev, J., Everts, V., & Karsdal, M. A. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0006 · Cited by 230
Wnt4 signaling prevents skeletal aging and inflammation by inhibiting nuclear factor-κB
Yu, B., Chang, J., Liu, Y., Li, J., Kevork, K., Al-Hezaimi, K., Graves, D. T., Park, N.-H., & Wang, C.-Y. (2014) · Nature Medicine · doi:10.1038/nm.3586 · Cited by 230
Review article: vitamin D and inflammatory bowel diseases
Mouli, V. P., & Ananthakrishnan, A. N. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12553 · Cited by 226
Bone remodeling in rheumatic disease: a question of balance
Walsh, N. C., & Gravallese, E. M. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00857.x · Cited by 230
Osteoclasts, rheumatoid arthritis, and osteoimmunology
Sato, K., & Takayanagi, H. (2006) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000231912.24740.a5 · Cited by 223
Osteoimmunology: Crosstalk Between the Immune and Bone Systems
Nakashima, T., & Takayanagi, H. (2009) · Journal of Clinical Immunology · doi:10.1007/s10875-009-9316-6 · Cited by 216
Treatment of arthritis with a selective inhibitor of c-Fos/activator protein-1
Aikawa, Y., Morimoto, K., Yamamoto, T., Chaki, H., Hashiramoto, A., Narita, H., Hirono, S., & Shiozawa, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1412 · Cited by 214
Regulatory T Cells Protect from Local and Systemic Bone Destruction in Arthritis
Zaiss, M. M., Frey, B., Hess, A., Zwerina, J., Luther, J., Nimmerjahn, F., Engelke, K., Kollias, G., Hünig, T., Schett, G., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903841 · Cited by 205
Self-citationGreen tea polyphenol epigallocatechi3-gallate: Inflammation and arthritis
Singh, R., Akhtar, N., & Haqqi, T. M. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.04.013 · Cited by 203
Zannettino, A. C. W., Farrugia, A. N., Kortesidis, A., Manavis, J., To, L. B., Martin, S. K., Diamond, P., Tamamura, H., Lapidot, T., Fujii, N., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1687 · Cited by 205
Yao, Z., Li, P., Zhang, Q., Schwarz, E. M., Keng, P., Arbini, A., Boyce, B. F., & Xing, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512624200 · Cited by 192
Aletaha, D., Funovits, J., & Smolen, J. S. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.138693 · Cited by 194
Self-citationInterplay between interferon and other cytokine systems in bone metabolism
Takayanagi, H., Sato, K., Takaoka, A., & Taniguchi, T. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00337.x · Cited by 191
Kitaura, H., Sands, M. S., Aya, K., Zhou, P., Hirayama, T., Uthgenannt, B., Wei, S., Takeshita, S., Novack, D. V., Silva, M. J., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.8.4838 · Cited by 190
Bone Damage in Rheumatoid Arthritis: Mechanistic Insights and Approaches to Prevention
Karmakar, S., Kay, J., & Gravallese, E. M. (2010) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2010.03.003 · Cited by 186
Mechanisms of Disease: the link between RANKL and arthritic bone disease
Schett, G., Hayer, S., Zwerina, J., Redlich, K., & Smolen, J. S. (2005) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0036 · Cited by 191
Self-citationEvidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis
Lories, R. J. U., Derese, I., de Bari, C., & Luyten, F. P. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22372 · Cited by 187
Osteoporosis in inflammatory joint diseases
Roux, C. (2011) · Osteoporosis International · doi:10.1007/s00198-010-1319-x · Cited by 180
Geusens, P. P., Landewé, R. B. M., Garnero, P., Chen, D., Dunstan, C. R., Lems, W. F., Stinissen, P., van der Heijde, D. M. F. M., van der Linden, S., & Boers, M. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21896 · Cited by 182
The development of novel therapies for rheumatoid arthritis
Quan, L.-D., Thiele, G. M., Tian, J., & Wang, D. (2008) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.18.7.723 · Cited by 181
Hayer, S., Vervoordeldonk, M. J., Denis, M. C., Armaka, M., Hoffmann, M., Bäcklund, J., Nandakumar, K. S., Niederreiter, B., Geka, C., Fischer, A., et al. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-219247 · Cited by 168
Self-citationCejka, D., Hayer, S., Niederreiter, B., Sieghart, W., Fuereder, T., Zwerina, J., & Schett, G. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27504 · Cited by 174
Self-citationTateiwa, D., Yoshikawa, H., & Kaito, T. (2019) · Cells · doi:10.3390/cells8080818 · Cited by 172
V-ATPases in osteoclasts: Structure, function and potential inhibitors of bone resorption
Qin, A., Cheng, T. S., Pavlos, N. J., Lin, Z., Dai, K., & Zheng, M. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.05.014 · Cited by 187
12/15-Lipoxygenase Counteracts Inflammation and Tissue Damage in Arthritis
Krönke, G., Katzenbeisser, J., Uderhardt, S., Zaiss, M. M., Scholtysek, C., Schabbauer, G., Zarbock, A., Koenders, M. I., Axmann, R., Zwerina, J., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900327 · Cited by 163
Self-citationWidaa, A., Claro, T., Foster, T. J., O’Brien, F. J., & Kerrigan, S. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040586 · Cited by 161
Osteoimmunology: Inflammatory osteolysis and regeneration of the alveolar bone
Gruber, R. (2019) · Journal of Clinical Periodontology · doi:10.1111/jcpe.13056 · Cited by 159
Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts
Komano, Y., Nanki, T., Hayashida, K., Taniguchi, K., & Miyasaka, N. (2006) · Arthritis Research & Therapy · doi:10.1186/ar2046 · Cited by 170
Dalbeth, N., Smith, T., Nicolson, B., Clark, B., Callon, K. E., Naot, D., Haskard, D. O., McQueen, F. M., Reid, I. R., & Cornish, J. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23488 · Cited by 166
Resolution of inflammation induces osteoblast function and regulates the Wnt signaling pathway
Matzelle, M. M., Gallant, M. A., Condon, K. W., Walsh, N. C., Manning, C. A., Stein, G. S., Lian, J. B., Burr, D. B., & Gravallese, E. M. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33504 · Cited by 149
RANK‐Independent Osteoclast Formation and Bone Erosion in Inflammatory Arthritis
O'Brien, W., Fissel, B. M., Maeda, Y., Yan, J., Ge, X., Gravallese, E. M., Aliprantis, A. O., & Charles, J. F. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39837 · Cited by 147
Jarrett, S. J., Conaghan, P. G., Sloan, V. S., Papanastasiou, P., Ortmann, C.-E., O’Connor, P., Grainger, A. J., & Emery, P. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21824 · Cited by 152
Pettit, A. R., Walsh, N. C., Manning, C., Goldring, S. R., & Gravallese, E. M. (2006) · Rheumatology · doi:10.1093/rheumatology/kel045 · Cited by 151
NF-κB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism
Yao, Z., Xing, L., & Boyce, B. F. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38716 · Cited by 149
Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice.
Schett, G., Redlich, K., Hayer, S., Zwerina, J., Bolon, B., Dunstan, C., Görtz, B., Schulz, A., Bergmeister, H., Kollias, G., et al. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11150 · Cited by 150
Self-citationSupplementation of diet with krill oil protects against experimental rheumatoid arthritis
Ierna, M., Kerr, A., Scales, H., Berge, K., & Griinari, M. (2010) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-11-136 · Cited by 147
Quinones, M. P., Ahuja, S. K., Jimenez, F., Schaefer, J., Garavito, E., Rao, A., Chenaux, G., Reddick, R. L., Kuziel, W. A., & Ahuja, S. S. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420126 · Cited by 149
Vaillancourt, F., Silva, P. J., Shi, Q., Fahmi, H., Fernandes, J., & Benderdour, M. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22884 · Cited by 145
Nandakumar, K. S., Bäcklund, J., Vestberg, M., & Holmdahl, R. (2004) · Arthritis Research & Therapy · doi:10.1186/ar1217 · Cited by 145
Aletaha, D., & Smolen, J. S. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30634 · Cited by 156
Self-citationSclerostin inhibition promotes TNF-dependent inflammatory joint destruction
Wehmeyer, C., Frank, S., Beckmann, D., Böttcher, M., Cromme, C., König, U., Fennen, M., Held, A., Paruzel, P., Hartmann, C., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aac4351 · Cited by 138
Interaction between Synovial Inflammatory Tissue and Bone Marrow in Rheumatoid Arthritis
Jimenez-Boj, E., Redlich, K., Türk, B., Hanslik-Schnabel, B., Wanivenhaus, A., Chott, A., Smolen, J. S., & Schett, G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2579 · Cited by 139
Self-citationImpact of Inflammation on the Osteoblast in Rheumatic Diseases
Baum, R., & Gravallese, E. M. (2013) · Current Osteoporosis Reports · doi:10.1007/s11914-013-0183-y · Cited by 142
Smolen, J. S., Ávila, J. C. M., & Aletaha, D. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200395 · Cited by 142
Self-citationRedlich, K., Görtz, B., Hayer, S., Zwerina, J., Doerr, N., Kostenuik, P., Bergmeister, H., Kollias, G., Steiner, G., Smolen, J. S., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63144-6 · Cited by 134
Self-citationDeng, G., Zheng, L., Chan, F. K.-M., & Lenardo, M. J. (2005) · Nature Medicine · doi:10.1038/nm1304 · Cited by 142
Activation of p38 MAPK is a key step in tumor necrosis factor–mediated inflammatory bone destruction
Zwerina, J., Hayer, S., Redlich, K., Bobacz, K., Kollias, G., Smolen, J. S., & Schett, G. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21626 · Cited by 132
Self-citationHeme oxygenase 1 (HO‐1) regulates osteoclastogenesis and bone resorption
Zwerina, J., Tzima, S., Hayer, S., Redlich, K., Hoffmann, O., Hanslik‐Schnabel, B., Smolen, J. S., Kollias, G., & Schett, G. (2005) · The FASEB Journal · doi:10.1096/fj.05-4278fje · Cited by 127
Self-citationGrassi, F., Cristino, S., Toneguzzi, S., Piacentini, A., Facchini, A., & Lisignoli, G. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10445 · Cited by 129
Bone Loss in Rheumatoid Arthritis: Basic Mechanisms and Clinical Implications
Shim, J., Stavre, Z., & Gravallese, E. M. (2017) · Calcified Tissue International · doi:10.1007/s00223-017-0373-1 · Cited by 141
Long term high intensity exercise and damage of small joints in rheumatoid arthritis
de Jong, Z., Munneke, M., Zwinderman, A. H., Kroon, H. M., Ronday, K. H., Lems, W. F., Dijkmans, B. A. C., Breedveld, F. C., Vlieland, T. P. M. V., Hazes, J. M. W., et al. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.015826 · Cited by 143
Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen‐induced arthritis
Sims, N. A., Green, J. R., Glatt, M., Schlicht, S., Martin, T. J., Gillespie, M. T., & Romas, E. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20382 · Cited by 128
Rheumatoid Arthritis in the View of Osteoimmunology
Auréal, M., Machuca‐Gayet, I., & Coury, F. (2020) · Biomolecules · doi:10.3390/biom11010048 · Cited by 136
Schett, G., & Teitelbaum, S. L. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090533 · Cited by 119
Self-citationOsteoclast precursors: cytokine-stimulated immunomodulators of inflammatory bone disease
Boyce, B. F., Schwarz, E. M., & Xing, L. (2006) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000231913.32364.32 · Cited by 122
Review: Immune cells and mediators of inflammatory arthritis
Schett, G. A. (2008) · Autoimmunity · doi:10.1080/08916930701694717 · Cited by 134
Self-citationBone loss in inflammatory arthritis: mechanisms and treatment strategies
Walsh, N. C., & Gravallese, E. M. (2004) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000127824.42507.68 · Cited by 124
Hoff, M., Haugeberg, G., Ødegård, S., Syversen, S. W., Landewé, R., van der Heijde, D. M. F. M., & Kvien, T. K. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.085985 · Cited by 127
Genetic deficiency of Syk protects mice from autoantibody‐induced arthritis
Jakus, Z., Simon, E., Balázs, B., & Mócsai, A. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27438 · Cited by 113
How antirheumatic drugs protect joints from damage in rheumatoid arthritis
Schett, G., Stach, C., Zwerina, J., Voll, R., & Manger, B. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23951 · Cited by 112
Self-citationZaiss, M. M., Kurowska-Stolarska, M., Böhm, C., Gary, R., Scholtysek, C., Stolarski, B., Reilly, J., Kerr, S., Millar, N. L., Kamradt, T., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003487 · Cited by 109
Self-citationMaruyama, K., Muramatsu, H., Ishiguro, N., & Muramatsu, T. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20175 · Cited by 123
Morinobu, A., Biao, W., Tanaka, S., Horiuchi, M., Liu, J., Tsuji, G., Sakai, Y., Kurosaka, M., & Kumagai, S. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23594 · Cited by 120
Herrak, P., Görtz, B., Hayer, S., Redlich, K., Reiter, E., Gasser, J., Bergmeister, H., Kollias, G., Smolen, J. S., & Schett, G. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20384 · Cited by 110
Self-citation
Metadata
- Authors
- Redlich, K., Hayer, S., Ricci, R., David, J.-P., Tohidast-Akrad, M., Kollias, G., Steiner, G., Smolen, J. S., Wagner, E. F., & Schett, G.
- Affiliations
- University of Vienna (AT)
- Vienna Biocenter (AT)
- Research Institute of Molecular Pathology (AT)
- Alexander Fleming Biomedical Sciences Research Center (GR)
- Corresponding author
- Schett, Georg
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2002-11-15
- Volume
- 110
- Issue
- 10
- Pages
- 1419-1427
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W4248559208
- Cited by
- 474
- References
- 40
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 11 · 2023: 11 · 2022: 11 · 2021: 12 · 2020: 24 · 2019: 16 · 2018: 16 · 2017: 15 · 2016: 16 · 2015: 24 · 2014: 22 · 2013: 25 · 2012: 29
- FWCI
- 11.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Funders
- Austrian Science Fund
- Oesterreichische Nationalbank
- Topics
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
- Keywords
- osteoclasts, TNF-α, rheumatoid arthritis, joint destruction, bone erosion, osteopetrotic mice, transgenic mice, synovitis, cartilage damage, matrix metalloproteinases, MMP-13, MMP-3, MMP-9, chondrocytes, osteoclast inhibition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.